Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AMP Health vs Rebody Health

AMP Health
Site position #311

Lower grade

vs+5.6
Rebody Health
Site position #178

Higher grade

The verdict

Rebody Health takes it — 67.7/100 to 62.1/100.

Rebody Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAMP Health +14
60
46
Dose & formulationEven
88
88
Clinical oversightRebody Health +26
55
81
Labs & monitoringRebody Health +1
52
53
FulfillmentRebody Health +22
62
84
Contract termsRebody Health +14
41
55
AMP Health · left barRebody Health · right bar

The numbers

MetricAMP HealthRebody Health
WeighScore62.1/10067.7/100
GradeCC
Site position#311#178
Semaglutide$199/mo (compounded)$200/mo (starting dose, compounded)
Tirzepatide$309/mo (compounded)$250/mo (starting dose, compounded)
CoverageCoverage not published47 states
Brand-name accessYesYes
Oral / sublingualYesYes
AMP Health

Site position #311 · C

FDAWarning letter issued to Dripgym Mobile Parent, LLC dba Amp Health in February 2026. See the FDA warning-letter database.

Strengths

  • Semaglutide in both injectable and oral formats
  • Tirzepatide available
  • 30-day satisfaction guarantee
  • Personal nutrition plan and health coaching included

Where it loses points

  • $79/mo subscription fee on top of medication ($278–$388/mo total)
  • No visible LegitScript or PCAB accreditation
  • No physical address disclosed
  • States served not disclosed
  • FDA issued Dripgym Mobile Parent, LLC dba Amp Health a warning letter in February 2026; the letter is public in FDA's warning-letter database
Rebody Health

Site position #178 · C

Strengths

  • Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
  • Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
  • Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
  • Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
  • Names its operating company (Compound Technologies Inc.) and references LegitScript approval

Where it loses points

  • Individual compounding pharmacies are not named on the marketing site
  • Not available in Massachusetts, Rhode Island, or Vermont
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard